Form D Explorer
Kaida BioPharma Inc. · CIK 1973954

Report a data issueCitable research briefCompare issuerPrivate research collection

Kaida BioPharma Inc.

CIK 1973954 · Corporation · Inc. DELAWARE · FORT LAUDERDALE, Florida · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
1
Amendments
1
Activity
Jan 21, 2026
through Sep 1, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldJan 21, 2026 · DSep 1, 2026 · D/ALater minus earlier
Reported offering amount$3,000,000$4,100,507$1,100,507
Reported amount sold$1,570,507$1,600,507$30,000
Reported investor count—44—
Reported minimum investment$0$0$0

Earlier SEC source: 0001493152-26-003028 · Later SEC source: 0001493152-26-040893

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D/A · Sep 1, 2026

Reported offering amount
$4,100,507
Reported exemptions
Rule 506(b)
Reported amount sold
$1,600,507

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Same reported sales compensation recipient

Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.

Form D filings (2)